Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Preferred Dividend Payments: 2019-2020

Historic Preferred Dividend Payments for Beam Therapeutics (BEAM) over the last 1 years, with Mar 2020 value amounting to $1.3 million.

  • Beam Therapeutics' Preferred Dividend Payments was N/A to $1.3 million in Q1 2020 from the same period last year, while for Mar 2020 it was $10.8 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2020, which is 89.96% down from last year.
  • Latest data reveals that Beam Therapeutics reported Preferred Dividend Payments of $1.3 million as of Q1 2020, which was down 60.86% from $3.3 million recorded in Q4 2019.
  • In the past 5 years, Beam Therapeutics' Preferred Dividend Payments ranged from a high of $3.3 million in Q4 2019 and a low of $1.3 million during Q1 2020.
  • Its 2-year average for Preferred Dividend Payments is $2.7 million, with a median of $3.1 million in 2019.